SGP
SpyGlass Pharma, Inc.Company with tickers: SGP
CIK
1778922
CUSIP
85220G109
Shares Outstanding
33,433,355
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $15,409,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $8,542,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-15,409,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-13,818,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.69 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.69 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |